Remove Doctors Remove Health Technology Remove Pharmaceuticals Remove Regulations
article thumbnail

The Gains and Pains of Using AI in the Pharmaceutical Industry

HIT Consultant

Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most importantly the high failure rate. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million.

article thumbnail

Roundups: 16 Recent Strategic Digital Health Partnerships

HIT Consultant

The CCPC project aims to allow patients to continue their care at home after discharge through the development of new predictive analytics, AI, and home monitoring technology that integrates with current medical systems for uninterrupted care from hospital to home. FIGS, Inc. ,

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Mortal Sins of Orphan Drug Development: How to Save the Lost Souls

Bill Of Health

In a working paper from November 2020 , the EU Commission finds a significant inefficiency in the EU orphan drug regulation (a pan-EU piece of legislation): that it does not contain a provision to safeguard the affordability and accessibility of orphan medicines. But, is the orphan drug regulation the right place for this type of law?

article thumbnail

Healthcare Is Changing, Right? Here’s 5 Reasons It’s Not.

HIT Consultant

Despite years of investment in health technology and infrastructure, healthcare systems still rely heavily on patchy legacy systems that are not always up to the task of supporting evidence-based decision-making and advanced analytics. Getting information from one doctor to another? It’s all about the money, money, money.

article thumbnail

Reproductive Health Technologies: From Design Feature to Defect

Bill Of Health

That these individuals are at the receiving end of these technologies is explicitly emphasized in the publicity of some reproductive health technology companies. The post Reproductive Health Technologies: From Design Feature to Defect appeared first on Bill of Health.

article thumbnail

Newsletter, February 2024

Patient Safety Movement

This brings up the concept of wearable digital health technologies for monitoring. The contributions of female doctors to healthcare are immeasurable, not only in their clinical expertise but also in their ability to foster environments where patients and families are empowered to be active participants in their care.